Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
Peptides
86
118
125
https://pubmed.ncbi.nlm.nih.gov/27780736/